Cartesian Therapeutics
RNAC
#6732
Rank
$0.47 B
Marketcap
$19.80
Share price
3.61%
Change (1 day)
-40.00%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2023 (TTM): -$0.32

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.32. In 2021 the company made an earnings per share (EPS) of -$0.24 an increase over its 2020 EPS that were of -$0.69.

EPS history for Cartesian Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.32
2021-$0.24-65.22%
2020-$0.69-43.44%
2019-$1.22-58.08%
2018-$2.91-9.35%
2017-$3.21-29.16%
2016-$4.53